| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |